1. Home
  2. IVDA vs ICCM Comparison

IVDA vs ICCM Comparison

Compare IVDA & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

N/A

Current Price

$0.19

Market Cap

3.7M

Sector

Technology

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

N/A

Current Price

$0.99

Market Cap

3.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IVDA
ICCM
Founded
2003
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.6M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
IVDA
ICCM
Price
$0.19
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $22.67
AVG Volume (30 Days)
115.8K
★ 133.6K
Earning Date
11-16-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.38
N/A
EPS
N/A
★ N/A
Revenue
★ $4,468,279.00
N/A
Revenue This Year
N/A
$20.80
Revenue Next Year
N/A
$115.66
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.13
52 Week High
$1.52
$9.54

Technical Indicators

Market Signals
Indicator
IVDA
ICCM
Relative Strength Index (RSI) 33.66 51.77
Support Level $0.18 $0.96
Resistance Level $0.34 $2.50
Average True Range (ATR) 0.02 0.11
MACD -0.00 0.06
Stochastic Oscillator 10.87 72.92

Price Performance

Historical Comparison
IVDA
ICCM

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: